Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these receptors, https://lillitbsd671625.newbigblog.com/42448050/retatrutide-a-promising-new-treatment-for-obesity